SALEM, Ore.--(BUSINESS WIRE)--Aurora Diagnostics announced today that it has acquired Pacific Pathology Associates, a hospital-based practice providing professional and technical pathology services to five hospitals and more than 225 physicians’ offices in 17 cities in the Willamette Valley area.
The acquisition establishes Aurora Diagnostics in the Pacific Northwest region. Notably, this is the seventh acquisition that Aurora Diagnostics has successfully completed since 2013 under its current management team. With this acquisition, Aurora Diagnostics now operates 25 labs.
Pacific Pathology Associates operates one technical processing lab near Salem Hospital. The practice provides extensive pathology services, including surgical pathology, cytopathology, hematopathology, immunohistochemistry, flow cytometry, fine needle aspiration, and bone marrow aspiration and biopsy.
“We are pleased to welcome the successful team at Pacific Pathology Associates to Aurora Diagnostics,” said Daniel D. Crowley, President, Chairman and CEO of Aurora Diagnostics. “As the only pathology group of its kind in the region, Pacific Pathology Associates is relied upon to provide exceptional pathology services. We will help the group reach out to new clients and maintain its reputation for premier inpatient and outpatient pathology services.”
“Joining the Aurora Diagnostics team provides Pacific Pathology Associates with additional resources and new capabilities to serve our community,” said Clark McDonald, M.D., the Board-certified pathologist who led the ownership group of Pacific Pathology Associates and who will continue to lead the local lab after the transaction. “Aurora has a reputation for affiliating with high quality labs that maintain strong local relationships. This, together with our excellent team and unique role in serving this community, will help make this a successful relationship for our clients.”
This acquisition is Aurora’s fifth in the hospital laboratory sector since 2013. Serving 85 hospitals throughout the U.S., the Company is a leader in outsourced hospital lab management services. Additionally, its Aurora Research Institute subsidiary is a leader in helping hospitals and independent labs to ethically provide tissue and blood samples to researchers on the cutting edge of research for effective cancer treatments.
“This acquisition builds on our ability to meet the needs of hospitals in the rapidly changing healthcare environment,” said Mr. Crowley.
Terms of the transaction were not disclosed.
About Aurora Diagnostics
Aurora Diagnostics is the leading independent specialized laboratory company focused on anatomic pathology at 25 locations in the United States. Employing over 150 licensed physicians, Aurora Diagnostics provides high-quality diagnostics and testing information for the patients of its primary referral sources—dermatologists, OB/GYN professionals, gastroenterologists, urologists, general surgeons, oncologists, and for 85 community hospitals. For additional information regarding Aurora Diagnostics and the services it provides, please visit the company website at www.auroradx.com.
